| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| NEVRO CORP | Chief Commercial Officer | Common Stock | 85,967 | $1,666,900 | $19.39 | 28 May 2023 | Direct |
| Acutus Medical, Inc. | Director | Common Stock | 12,572 | $19,612 | $1.56 | 16 Jun 2022 | Direct |
| Acutus Medical, Inc. | Director | FORM 4 | 20,972 | $3,964 | $0.1890 | 15 Jun 2023 | Direct |
| Acutus Medical, Inc. | Director | Stock Options (Right to Buy) | 19,600 | 16 Jun 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| AFIB | Acutus Medical, Inc. | 15 Jun 2023 | 2 | $0 | 4 | Director | 15 Jun 2023, 18:06 |
| NVRO | NEVRO CORP | 28 May 2023 | 1 | -$30,232 | 4 | Chief Commercial Officer | 31 May 2023, 19:02 |
| NVRO | NEVRO CORP | 07 Mar 2023 | 1 | $0 | 4 | Chief Commercial Officer | 09 Mar 2023, 15:57 |
| NVRO | NEVRO CORP | 02 Mar 2023 | 1 | -$67,266 | 4 | Chief Commercial Officer | 06 Mar 2023, 17:43 |
| NVRO | NEVRO CORP | 28 Feb 2023 | 1 | -$148,334 | 4 | Chief Commercial Officer | 02 Mar 2023, 15:34 |
| NVRO | NEVRO CORP | 06 Aug 2022 | 1 | -$205,635 | 4 | Chief Commercial Officer | 08 Aug 2022, 20:26 |
| AFIB | Acutus Medical, Inc. | 16 Jun 2022 | 2 | $0 | 4 | Director | 21 Jun 2022, 17:41 |
| NVRO | NEVRO CORP | 02 Mar 2022 | 1 | -$144,749 | 4 | Chief Commercial Officer | 04 Mar 2022, 18:14 |
| NVRO | NEVRO CORP | 28 Feb 2022 | 1 | $0 | 4 | Chief Commercial Officer | 02 Mar 2022, 20:02 |
| AFIB | Acutus Medical, Inc. | 10 Aug 2021 | 2 | $0 | 4 | Director | 12 Aug 2021, 16:49 |
| AFIB | Acutus Medical, Inc. | 10 Aug 2021 | 0 | $0 | 3 | Director | 12 Aug 2021, 16:34 |
| NVRO | NEVRO CORP | 06 Aug 2021 | 1 | -$522,741 | 4 | Chief Commercial Officer | 10 Aug 2021, 16:27 |